[September 01, 2014] |
|
Research and Markets: 2014 Opportunities in the US Infectious Disease Testing Market
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/5jq957/2014)
has announced the addition of the "2014
Opportunities in the US Infectious Disease Testing Market"
report to their offering.
2014 Opportunities in the US Infectious Disease Testing Market is a new
strategic analysis of major business opportunities emerging in the
infectious disease testing market during the next five years. The report
examines key US market trends; reviews current and emerging assays;
analyzes potential applications of innovative diagnostic technologies;
forecasts volume and sales for over 100 infectious disease tests by
assay, and market segment; provides test volume estimates by method
(molecular, serology/immunodiagnostics, culture/microscopy); profiles
leading players and potential market entrants; and suggests alternative
business expansion strategies for suppliers.
Opportunities and Strategic Recommendations
-
Emerging opportunities for new instrumentation, reagents kits, IT and
other products with significant market appeal during the next five
years.
-
Design criteria for decentralized testing products.
-
Alternative market penetration strategies.
-
Potential market entry barriers and risks.
Volume and sales forecasts for over 100 infectious disease
assays by individual test and market segment:
-
Hospitals
-
Blood Banks
-
Commercial/Private Laboratories
-
Physician Offices/Group Practices
-
Public Health Laboratories
-
Test volume estimates by method (molecular,
serology/immunodiagnostics, culture/microscopy).
-
Review of the market dynamics, trends, structure, size, growth and
major suppliers.
Current and Emerging Products
-
In-depth examination of over 100 major diseases, including their
etiology, current diagnostic tests, vaccines, drugs and market needs.
-
Review of major analyzers used for infectious disease testing,
including their operating characteristics, features and selling prices.
Technology Review
-
Assessment of molecular diagnostic, monoclonal antibody, immunoassay,
and other technologies and their potential applications for infectious
disease testing.
-
Global listings of companies developing or marketing infectious
disease diagnostic products by individual test.
Key Topics Covered:
I. Introduction
II. Major Product Development Opportunities
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
V. Potential Market Entry Barriers and Risks
VI. Worldwide Overview of Major Tests
Companies Mentioned
-
Abbott
-
Affymetrix
-
Beckman Coulter/Danaher (News - Alert)
-
Becton Dickinson
-
bioMerieux
-
Bio-Rad
-
Cepheid
-
Diamedix
-
DiaSorin
-
Eiken Chemical
-
Enzo Biochem
-
Fujirebio/Innogenetics
-
Hologic/Gen-Probe
-
ID Biomedical/GSK
-
Kreatech
-
Life Technology
-
Lonza
-
Nanogen/Elitech
-
Novartis Diagnostics
-
Ortho-Clinical Diagnostics
-
Qiagen
-
Roche
-
Scienion
-
Sequenom
-
SeraCare
-
Siemens (News - Alert)
-
Takara Bio
-
Thermo Fisher
-
Wallac/PE
-
Wako
For more information visit http://www.researchandmarkets.com/research/5jq957/2014
[ Back To TMCnet.com's Homepage ]
|